SCIENTIFIC BACKGROUND

ELANE

Category:

Heterozygous pathogenic variants in the ELANE gene, coding for neutrophil elastase, are causative for cyclic neutropenia (CyN) and for about 40-80% of severe congenital neutropenia (SCN). The exact pathomechanism by which ELANE variants lead to a lack of mature neutrophil granulocytes in the peripheral blood is not known. A direct role of neutrophil elastase in granulopoiesis has not yet been established. There is no clear genotype-phenotype correlation; some pathogenic variants have been identified in both CyN and SCN patients.

 

Cyclic neutropenia occurs every 2-3 weeks for approximately 1 week and is detected by regular monitoring of the neutrophil count over 2 months. In patients with well-documented cyclic neutropenia and known affected family members, the detection rate of pathogenic variants in the ELANE gene is 90-100%. CyN shows variable symptoms depending on the duration and severity of the neutropenia: severe bacterial infections, pneumonia, abscesses, lymphadenitis, stomatitis, skin and mucous membrane ulcerations, or only fever episodes, can occur.

 

SCN is characterized by a permanently severely reduced absolute number of neutrophil granulocytes in the peripheral blood, which leads to severe infections, pneumonia, otitis, stomatitis, abscesses, skin and mucous membrane ulcerations as early as the first year of life. The treatment of choice is the administration of G-CSF, a growth factor that stimulates the maturation of neutrophil granulocytes. The only causal treatment for the disease is blood stem cell transplantation.

 

The most common genetic cause of congenital neutropenia is pathogenic variants in the ELANE gene. In rarer cases, pathogenic variants are present in other SCN-associated genes. NGS panel analysis can be used to test other genes that are causally linked to neutropenia.

 

References

Spoor et al. 2019, Crit Rev Oncol Hematol 133:149 / Shearer et al. 2014, J Allergy Clin Immunol 133:1092 / Buckley et al. 1997, J Pediatr 130:378 / Puck et al. 1997, Blood 89:1968 / Puck et al. 1993, Hum Mol Genet 2:1099

GENES

ELANE

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more